To include your compound in the COVID-19 Resource Center, submit it here.
Roche and Seaside partnered to develop disease modifying treatments for fragile X syndrome and autism spectrum disorders. Seaside
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury